Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aranesp Q2W in Anemia of Chronic Renal Insufficiency
NCT00368901Phase 4Completed
- Sponsor
- Amgen
- Start
- Jan 2002
- Primary completion
- Mar 2004
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 4 trial of darbepoetin alfa in anemia of chronic kidney disease, sponsored by Amgen. Started Jan 2002; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00368901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368901.